ClassID:

21020

A61K38/42 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Porphyrin- or corrin-ring-containing peptides Haemoglobins; Myoglobins

Recent Application in this class:
#1
20260076917
2026-03-19

COMPOSITION AND PROCESS FOR A LIPID NANO-PARTICLE DELIVERY OF OXYGEN AND VITAL METABOLIC COMPOUNDS FOR HEMORRHAGIC SHOCK

#2
20250381295
2025-12-18

LENTIVIRAL VECTORS EXPRESSING ALPHA-GLOBIN GENES FOR GENE THERAPY OF ALPHA THALASSEMIA

#3
20250368757
2025-12-04

PARTICLES COMPRISING PROTEINS ENCAPSULATED IN A POROUS FRAMEWORK AND METHODS OF USING THEREOF

#4
20250367268
2025-12-04

Compositions and Methods for Treating Internal Bleeding and Hemorrhage

#5
20250304655
2025-10-02

Expression System for Producing a Recombinant Haptoglobin (Hp) Beta Chain

#6
20250302994
2025-10-02

ERYTHROPARVOVIRUS WITH A MODIFIED GENOME FOR GENE THERAPY

#7
20250295810
2025-09-25

ERYTHROPARVOVIRUS WITH A MODIFIED CAPSID FOR GENE THERAPY

#8
20250276046
2025-09-04

SELF-ASSEMBLING OXYGEN CARRIER COMPOSITIONS

#9
20250242047
2025-07-31

PROTEIN-ENCLOSING POLYMERIC MICELLE

#10
20250215427
2025-07-03

Materials and Methods for Treatment of Hemoglobinopathies

#11
20250195556
2025-06-19

COMPOSITIONS, KITS, AND METHODS TO INDUCE ACQUIRED CYTORESISTANCE USING STRESS PROTEIN INDUCERS

#12
20250144149
2025-05-08

ADENOSINE DEAMINASE BASE EDITORS AND METHODS FOR USE THEREOF

#13
20250084437
2025-03-13

RECOMBINANT LENTIVIRAL VECTOR FOR STEM CELL-BASED GENE THERAPY OF SICKLE CELL DISORDER

#14
20250018013
2025-01-16

COMPOSITION INCLUDING MICROBIAL HEMOPROTEIN EXTRACT FOR IMPROVING INTESTINAL FUNCTION AND OBESITY

#15
20240366796
2024-11-07

Erythroid Specific Enhancers

#16
20240350664
2024-10-24

GENE THERAPY BASED ADMINISTRATION OF LENTIVIRUS VECTOR FOR TREATING HEMOGLOBINOPATHIES

#17
20240335561
2024-10-10

A METHOD FOR IN VIVO GENE THERAPY TO CURE SCD WITHOUT MYELOABLATIVE TOXICITY

#18
20240226188
2024-07-11

COMPOSITIONS COMPRISING ANIMAL HEMOGLOBIN

#19
20240216534
2024-07-04

DIRECT RAAV-MEDIATED IN VIVO GENE EDITING OF HEMATOPOIETIC STEM CELLS

#20
20240156918
2024-05-16

GEL BASED ON ANNELID HEMOGLOBIN

#21
20240131083
2024-04-25

COMPOSITIONS COMPRISING ANIMAL HEMOGLOBIN

#22
20240108646
2024-04-04

Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers

#23
20230355534
2023-11-09

METHOD TO ENCAPSULATE AN AQUEOUS SOLUTION COMPRISING A COMPOUND OF INTEREST IN A MATRIX

#24
20230330185
2023-10-19

METHODS AND COMPOSITIONS FOR TRANSDUCING HEMATOPOIETIC STEM AND PROGENITOR CELLS IN VIVO

#25
20230321200
2023-10-12

SILK PARTICLES ENCAPSULATING OXYGEN CARRIERS AS ARTIFICIAL BLOOD SUBSTITUTE

#26
20230310554
2023-10-05

MEDICINE CONTAINING METHEMOGLOBIN ENDOPLASMIC RETICULUM AS ACTIVE INGREDIENT AND USE THEREOF

#27
20230310506
2023-10-05

METHOD FOR ACTIVATING EXPRESSION OF GAMMA-GLOBIN GENE, AND COMPOSITION

#28
20230241184
2023-08-03

Compositions and Methods for Treating Hemorrhagic Shock

#29
20230136849
2023-05-04

CAPSID-MODIFIED RAAV VECTOR COMPOSITIONS AND METHODS THEREFOR

#30
20230090172
2023-03-23

BLOOD SUBSTITUTES COMPRISING HEMOGLOBIN AND METHOGS OF MAKING

#31
20230026348
2023-01-26

NITROXYLATED PROTEINS AND METHODS FOR THE USE THEREOF

#32
20220354930
2022-11-10

Hemoglobin Substitute Mixtures Including Reconstituted Plasma and Platelets and Their Manufacture and Use

#33
20220313792
2022-10-06

HEMOGLOBIN-BASED NANOPARTICLES FOR OXYGEN DELIVERY

#34
20220280616
2022-09-08

Thiosuccinyl-crosslinked hemoglobin conjugates and methods of use and preparation thereof

#35
20220280571
2022-09-08

COMPOSITIONS AND METHODS FOR TREATING ALPHA THALASSEMIA

#36
20220249689
2022-08-11

PROTEIN-ENCLOSING POLYMERIC MICELLE

#37
20220168384
2022-06-02

Anti-Bacterial Combination Therapy

#38
20220040333
2022-02-10

Use of neuroglobin agonist for preventing or treating mitochondrial RCCI and/or RCCIII deficiency disease

#39
20210401949
2021-12-30

Hemoglobin derivative co-conjugated with fatty acid-linked PEG and alkoxy PEG as a blood substitute

#40
20210401875
2021-12-30

Oxygen carriers for the treatment of skin indispositions

#41
20210369851
2021-12-02

Modified globin proteins

#42
20210330754
2021-10-28

Self-assembling oxygen carrier compositions

#43
20210317468
2021-10-14

SYNTHESIS AND STRUCTURE OF HIGH POTENCY RNA THERAPEUTICS

#44
20210317450
2021-10-14

MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES

#45
20210275567
2021-09-09

Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers

#46
20210260226
2021-08-26

Method and compositions for protecting tissue

#47
20210205419
2021-07-08

Reduced oxygen carriers and their use for the treatment of carboxyhemoglobinemia

#48
20210187019
2021-06-24

FOOD FACTOR-BASED FORMULATION, PRODUCTS PRODUCED USING SAID FORMULATION AND METHODS FOR PRODUCING SAME

#49
20210113471
2021-04-22

Annelid haemoglobin lyophilisation process

#50
20210060136
2021-03-04

USE OF HEMOGLOBIN FROM ANNELIDS AS BACTERICIDE, IN PARTICULAR FOR PREVENTING AND/OR TREATING A PERIODONTAL DISEASE

#51
20210009998
2021-01-14

Materials and methods for treatment of hemoglobinopathies

#52
20200368370
2020-11-26

Therapeutic retroviral vectors for gene therapy

#53
20200338361
2020-10-29

COMPOSITIONS AND METHODS FOR INDUCING NANOPARTICLE-MEDIATED MICROVASCULAR EMBOLIZATION FOR TUMORS

#54
20200316176
2020-10-08

Scarring reducing wound treatment

#55
20200297658
2020-09-24

Compositions and methods for treatment of cancer

#56
20200230285
2020-07-23

Wound spray

#57
20200222510
2020-07-16

Blood substitutes comprising hemoglobin and methods of making

#58
20200215167
2020-07-09

Lentiviral vector for treating hemoglobin disorders

#59
20200190536
2020-06-18

Recombinant lentiviral vector for stem cell- based gene therapy of sickle cell disorder

#60
20200138716
2020-05-07

COMPOSITIONS AND METHODS FOR INDUCING NANOPARTICLE-MEDIATED MICROVASCULAR EMBOLIZATION OF TUMORS

#61
20200102357
2020-04-02

Methods for treatment of nephrotic syndrome and related conditions

#62
20200062825
2020-02-27

Generation of hemoglobin-based oxygen carriers using elastin-like polypeptides

#63
20200054222
2020-02-20

Pulse wave detection device, image analysis device, and biometric information generation system

#64
20200038490
2020-02-06

Microparticles

#65
20200016242
2020-01-16

Hemoglobin based oxygen carrier and method of preparation

#66
20200009231
2020-01-09

Compositions and methods for improved encapsulation of functional proteins in polymeric vesicles

#67
20200009230
2020-01-09

Composition and methods for treating ischemic wounds and inflammatory conditions

#68
20200001110
2020-01-02

COMPOSITIONS AND METHODS FOR INDUCING NANOPARTICLE-MEDIATED MICROVASCULAR EMBOLIZATION FOR TUMORS

#69
20190390203
2019-12-26

REDUCTION OF LIPASE ACTIVITY IN PRODUCT FORMULATIONS

#70
20190358242
2019-11-28

COMPOSITIONS, KITS, AND METHODS TO INDUCE ACQUIRED CYTORESISTANCE USING STRESS PROTEIN INDUCERS

#71
20190290739
2019-09-26

Reduced oxygen carriers and their use for the treatment of carboxyhemoglobinemia

#72
20190201497
2019-07-04

Microparticles

#73
20190192676
2019-06-27

Immunostimulant

#74
20190183982
2019-06-20

POLYMERIC RED BLOOD CELL-LIKE PARTICLES

#75
20190127445
2019-05-02

Succinimide-activated nitroxyl compounds and methods for the use thereof for nitroxylation of proteins

#76
20190127424
2019-05-02

CAPSID-MODIFIED RAAV VECTOR COMPOSITIONS AND METHODS THEREFOR

#77
20190091255
2019-03-28

Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers

#78
20190076507
2019-03-14

Artificial Red Blood Cell Having Ability to Inhibit Conversion of Hemoglobin into Methemoglobin

#79
20190070301
2019-03-07

Activated polyoxazolines and conjugates and compositions comprising the same

#80
20190060239
2019-02-28

Technology for the Preparation of Microparticles

#81
20190038775
2019-02-07

Therapeutic retroviral vectors for gene therapy

#82
20190022190
2019-01-24

GENERATION OF HEMOGLOBIN-BASED OXYGEN CARRIERS USING ELASTIN LIKE POLYPEPTIDES

#83
20190016759
2019-01-17

Capsid-modified rAAV vector compositions and methods therefor

#84
20190002906
2019-01-03

Synthesis and structure of high potency RNA therapeutics

#85
20190000929
2019-01-03

Hemoglobin compositions

#86
20180369281
2018-12-27

Method of ameliorating side effects of sickle cell disease treatments

#87
20180284087
2018-10-04

Diagnosis and treatment of preeclampsia

#88
20180179545
2018-06-28

Reduction of lipase activity in product formulations

#89
20180105559
2018-04-19

AAV vectors with high transduction efficiency and uses thereof for gene therapy

#90
20180028449
2018-02-01

Technology for the Preparation of Microparticles

#91
20180021413
2018-01-25

Materials and methods for treatment of hemoglobinopathies

#92
20180008722
2018-01-11

Use of PLL for improving the stability of molecules in solution

#93
20180000905
2018-01-04

Composition and methods for treating ischemic wounds and inflammatory conditions

#94
20170361126
2017-12-21

Compositions and Methods for Inducing Nanoparticle Mediated Microvascular Embolization of Tumors

#95
20170360706
2017-12-21

COMPOSITIONS AND METHODS FOR INDUCING NANOPARTICLE-MEDIATED MICROVASCULAR EMBOLIZATION OF TUMORS

#96
20170355961
2017-12-14

METHOD OF ISOLATING CELLS FROM A TISSUE IN A MAMMAL

#97
20170333566
2017-11-23

Conjugated Proteins

#98
20170326086
2017-11-16

USE OF HEMOGLOBIN EFFECTORS TO INCREASE THE BIOAVAILABILITY OF THERAPEUTIC GASES

#99
20170304414
2017-10-26

Compositions and methods for the treatment of phenylketonuria (PKU)

#100
20170304410
2017-10-26

Treatment of cancer and inhibition of metastasis using hemoglobin beta subunit

#101
20170296630
2017-10-19

Lentiviral vector for treating hemoglobin disorders

#102
20170266285
2017-09-21

Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging

#103
20170224626
2017-08-10

Enteric-coated hemoglobin multiparticulate for oral delivery of hemoglobin based oxygen carriers

#104
20170173171
2017-06-22

Activated polyoxazolines and conjugates and compositions comprising the same

#105
20170112869
2017-04-27

Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers

#106
20170105929
2017-04-20

BIODEGRADABLE NANOPARTICLES AS NOVEL HEMOGLOBIN-BASED OXYGEN CARRIERS AND METHODS OF USING THE SAME

#107
20170072023
2017-03-16

Hemoglobin compositions

#108
20170049703
2017-02-23

Bioerodible silicon-based compositions for delivery of therapeutic agents

#109
20170000734
2017-01-05

Compositions and methods for improved encapsulation of functional proteins in polymeric vesicles

#110
20160375141
2016-12-29

Oral delivery system for hemoglobin based oxygen carriers

#111
20160355558
2016-12-08

Methods for treatment of nephrotic syndrome and related conditions

#112
20160346358
2016-12-01

Blood substitute composition and method of use

#113
20160312226
2016-10-27

Reduction of lipase activity in product formulations

#114
20160310414
2016-10-27

MICROPARTICLES, BLOOD SUBSTITUTE AND METHOD FOR FORMING SAME

#115
20160303049
2016-10-20

Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells

#116
20160279293
2016-09-29

Implantable preparations for regeneration of tissues and treatment of wounds, their method of preparation, and method of treatment of patients with said implantable preparations

#117
20160271164
2016-09-22

Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers

#118
20160263217
2016-09-15

PROTEIN-SPECIFIC FORMULATIONS

#119
20160235675
2016-08-18

Technology for the Preparation of Microparticles

#120
20160228602
2016-08-11

Wound spray

#121
20160184404
2016-06-30

NOVEL HEMOGLOBIN-DERIVED PEPTIDE BASED PHARMACEUTICAL COMPOSITIONS

#122
20160183554
2016-06-30

Use of nutritional supplement for increasing the bacterial mass in the rumen of a ruminant

#123
20160175478
2016-06-23

Use of a hemoglobin for the preparation of dressings and resulting dressings

#124
20160175403
2016-06-23

Scarring reducing wound treatment

#125
20160144048
2016-05-26

Pegylated Hemoglobin and Albumin and Uses Thereof

#126
20160136235
2016-05-19

Hemostatic compositions

#127
20160051635
2016-02-25

Blood substitute composition and method of use

#128
20160022839
2016-01-28

Therapeutic retroviral vectors for gene therapy

#129
20160022783
2016-01-28

Polyalkylene oxide valerate hemoglobin conjugates

#130
20160000864
2016-01-07

Pharmaceutical composition comprising recombinant hemoglobin protein or subunit-based therapeutic agent for cancer targeting treatment

#131
20150374796
2015-12-31

USE OF HAEMOGLOBIN OF ANNELIDS FOR TREATING CANCER

#132
20150359746
2015-12-17

Technology for the Preparation of Microparticles

#133
20150321204
2015-11-12

Method and apparatus for continuous removal of sub-micron sized particles in a closed loop liquid flow system

#134
20150313968
2015-11-05

Oral delivery for hemoglobin based oxygen carriers

#135
20150297669
2015-10-22

Pharmaceutical composition for treating medical conditions and a method for treating alimentary disorders and related diseases

#136
20150238432
2015-08-27

Synthesis of oxygen carrying, turbulence resistant, high density submicron particulates

#137
20150087590
2015-03-26

Diaspirin crosslinked pegylated hemoglobin

#138
20150064275
2015-03-05

Compositions for improved tissue oxygenation by peritoneal ventilation

#139
20150031599
2015-01-29

Hemoglobin compositions

#140
20150017146
2015-01-15

Method of enhancing efficacy of blood transfusions

#141
20140377237
2014-12-25

Methods of preparing cells and compositions

#142
20140371149
2014-12-18

SCARRING REDUCING WOUND TREATMENT

#143
20140341852
2014-11-20

Capsid-modified rAAV vector compositions and methods therefor

#144
20140335160
2014-11-13

Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same

#145
20140335159
2014-11-13

Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same

#146
20140335018
2014-11-13

Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging

#147
20140303085
2014-10-09

Hemoglobin-based oxygen carrier-containing pharmaceutical composition for cancer targeting treatment and prevention of cancer recurrence

#148
20140271886
2014-09-18

Bioerodible silicon-based compositions for delivery of therapeutic agents

#149
20140221944
2014-08-07

Wound spray

#150
20140221292
2014-08-07

Polyionic dendrimer and hydrogel comprising same

#151
20140212477
2014-07-31

HEMOGLOBIN-CONTAINING LIPOSOME AND METHOD FOR PRODUCING SAME

#152
20140194354
2014-07-10

Methods for treatment of nephrotic syndrome and related conditions

#153
20140161773
2014-06-12

Use of an agent that restores tissue perfusion and oxygenation

#154
20140147507
2014-05-29

CARBIDE-DERIVED-CARBON-BASED OXYGEN CARRIERS

#155
20140113859
2014-04-24

Use of liver growth factor (LGF) as a neural tissue regenerator

#156
20140113274
2014-04-24

Use of extracellular hemoglobin obtained from the marine worm, , for the preservation of organs, tissues, cells

#157
20140106004
2014-04-17

HEMOGLOBIN-BASED OXYGEN CARRIER-CONTAINING PHARMACEUTICAL COMPOSITION FOR CANCER TARGETING TREATMENT AND PREVENTION OF CANCER RECURRENCE

#158
20140011741
2014-01-09

Hemoglobin compositions

#159
20130336884
2013-12-19

Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells

#160
20130316455
2013-11-28

Method of isolating cells from a tissue in a mammal

#161
20130310305
2013-11-21

Methods for increasing plasmin activity and promoting plaque regression in the treatment of atherosclerosis

#162
20130307170
2013-11-21

Blood substitutes and uses thereof

#163
20130288949
2013-10-31

Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin

#164
20130261061
2013-10-03

Method of enhancing efficacy of blood transfusions

#165
20130102521
2013-04-25

COMPOSITIONS FOR OXYGEN TRANSPORT COMPRISING A HIGH OXYGEN AFFINITY MODIFIED HEMOGLOBIN

#166
20130059000
2013-03-07

Oral delivery for hemoglobin based oxygen carriers

#167
20130052232
2013-02-28

METHOD FOR THE PREPARATION OF A HEAT STABLE OXYGEN CARRIER-CONTAINING COMPOSITION FACILATING BETA-BETA CROSS-LINKING

#168
20120282236
2012-11-08

METHOD OF DELIVERING OXYGEN USING PEG-HEMOGLOBIN CONJUGATES WITH ENHANCED NITRITE REDUCTASE ACTIVITY

#169
20120225133
2012-09-06

Use of an agent that restores tissue perfusion and oxygenation

#170
20120220529
2012-08-30

NITRIC OXIDE-BLOCKED CROSS-LINKED TETRAMERIC HEMOGLOBIN

#171
20120195869
2012-08-02

Sickled erythrocytes with anti-tumor agents induce tumor vaso-occlusion and tumoricidal effects

#172
20120183501
2012-07-19

NOVEL METHOD FOR TREATMENT OF SKIN WOUNDS AND PREPARATIONS FOR IMPLEMENTATION OF SAME

#173
20120164231
2012-06-28

Synthesis Of Oxygen Carrying, Turbulence Resistant, High Density Submicron Particulates

#174
20120141590
2012-06-07

Technology for the Preparation of Microparticles

#175
20120101041
2012-04-26

POLYIONIC DENDRIMER AND HYDROGEL COMPRISING SAME

#176
20120094936
2012-04-19

MalPEG Hb conjugate-containing compositions for delivering nitric oxide (NO) to cells

#177
20120094912
2012-04-19

MalPEG-Hb conjugate-containing compositions for delivering carbon monoxide (CO) to cells

#178
20120077662
2012-03-29

Method And Apparatus For Continuous Removal Of Submicron Sized Particles In A Closed Loop Liquid Flow System

#179
20120028899
2012-02-02

COMPOSITION AND PROCESS FOR SYNTHESIZING TENSE AND RELAXED STATE POLYMERIZED HEMOGLOBIN

#180
20120009161
2012-01-12

Therapeutic retroviral vectors for gene therapy

#181
20120004396
2012-01-05

Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin

#182
20110319858
2011-12-29

METHOD FOR THE PREPARATION OF A HEAT STABLE OXYGEN CARRIER-CONTAINING PHARMACEUTICAL COMPOSITIONS AND THE USE THEREOF

#183
20110319332
2011-12-29

TREATMENT METHODS USING A HEAT STABLE OXYGEN CARRIER-CONTAINING PHARMACEUTICAL COMPOSITION

#184
20110295225
2011-12-01

Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof

#185
20110274669
2011-11-10

THERAPEUTIC RETROVIRAL VECTORS FOR GENE THERAPY

#186
20110256225
2011-10-20

Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same

#187
20110200981
2011-08-18

Polymerized Hemoglobin Media And Its Use In Isolation And Transplantation of Islet Cells

#188
20110151007
2011-06-23

Carbide-derived-carbon-based oxygen carriers

#189
20110142808
2011-06-16

Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells

#190
20110014178
2011-01-20

Antimicrobial Composition and Method for Use

#191
20110008381
2011-01-13

SUPPRESSION OF ALLERGIC INFLAMMATION BY ASCARIS HEME-BINDING PROTEIN (HBP)

#192
20100323029
2010-12-23

Five-coordinate neuroglobin and use thereof as a blood substitute

#193
20100311657
2010-12-09

Hemoglobin compositions

#194
20100298222
2010-11-25

Use of an agent that restores tissue perfusion and oxygenation

#195
20100278887
2010-11-04

Use of a haemoglobin for the preparation of dressings and resulting dressings

#196
20100234275
2010-09-16

Use of a high molecular weight extracellular hemoglobin for the manufacture of a medicament for treating and/or preventing diseases by inhibition of calcium

#197
20100216695
2010-08-26

Second generation low oxygen affinity pegylated hemoglobins as oxygen-carrying plasma expanders

#198
20100209902
2010-08-19

Use of a globin, a globin protomer or an extracellular hemoglobin obtained from the marine worm, , for the preservation of organs, tissues, cells or cell cultures

#199
20100209532
2010-08-19

TARGETED OXYGEN DELIVERY VIA INTRAVENOUS OR INTRA-ARTERIAL INFUSION OF OXYGENATED POLYMERIZED HEMOGLOBIN SOLUTIONS

#200
20100209518
2010-08-19

Micro-particles, blood-substitute and method for forming same

#201
20100197566
2010-08-05

Method and Apparatus for Preparing an Acellular Red Blood Cell Substitute

#202
20100145298
2010-06-10

OXYGEN-CARRYING BLOOD SUBSTITUTE PREPARATIONS

#203
20100144597
2010-06-10

Novel combinatorial approaches to enhancing oxygen transport to tissues

#204
20100144595
2010-06-10

Lyophilization of Hemoglobin Solutions

#205
20100105606
2010-04-29

Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin

#206
20100105070
2010-04-29

Diagnosis and treatment of preeclampsia

#207
20100087361
2010-04-08

Method to enhance hemodynamic stability using oxygen carrying compositions

#208
20100062059
2010-03-11

S-Nitrosothiols Containing Composition for the Treatment of Fatty Liver Diseases, Obesity and Other Diseases Associated with the Metabolic Syndrome and the Use of Such Compositions

#209
20100051025
2010-03-04

Attenuation of vasoactive oxygen carrier-induced vasoconstriction

#210
20100041147
2010-02-18

HEMOGLOBIN ALPHA CHAIN PEPTIDE FRAGMENTS USEFUL FOR INHIBITING STEM CELL PROLIFERATION

#211
20100035798
2010-02-11

METHODS AND COMPOSITIONS FOR THE TOPICAL OXYGENATION OF HYPOXIC TISSUE

#212
20100035797
2010-02-11

Nitric oxide-blocked cross-linked tetrameric hemoglobin

#213
20100028994
2010-02-04

Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells

#214
20090312239
2009-12-17

Preparation, for use, in particular, for tissue augmentation and healing

#215
20090305289
2009-12-10

SCREENING METHOD TO IDENTIFY PROTECTIVE SUBSTANCES FOR THE TREATMENT OF NEURODEGENERATIVE AND/OR ISCHAEMIC DISEASES

#216
20090298746
2009-12-03

Pegylated albumin and uses thereof

#217
20090281021
2009-11-12

Composition and method for treating iron deficiency anemia

#218
20090232909
2009-09-17

Method for determining physiological effects of hemoglobin

#219
20090169591
2009-07-02

MEDICAL ARTICLES FOR THE TREATMENT OF TUMORS

#220
20090098207
2009-04-16

Technology for the Preparation of Microparticles

#221
20090082257
2009-03-26

MalPEG-Hb conjugate- containing compositions for delivering carbon monoxide (CO) to cells

#222
20090075866
2009-03-19

Method to enhance hemodynamic stability using oxygen carrying compositions

#223
20090074736
2009-03-19

IMPLANTABLE PREPARATIONS COMPRISING GLOBIN, PROCESS FOR THEIR PRODUCTION, AND USES

#224
20090048324
2009-02-19

Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules

#225
20090004159
2009-01-01

Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells

#226
20080247949
2008-10-09

Biological Tissue Examination Agent Comprising Hemoglobin Labeled With Oxygen Isotope And Method For Producing The Same

#227
20080220406
2008-09-11

Physiologically acceptable aqueous solutions and methods for their use

#228
20080193516
2008-08-14

OXYGEN-CARRYING BLOOD SUBSTITUTE PREPARATIONS

#229
20080175871
2008-07-24

ELICITING IMPROVED IMMUNE RESPONSES

#230
20080146493
2008-06-19

Use of Haptoglobin and Hemoglobin to Modulate Na Ion Transport in a Vertebrate

#231
20080118572
2008-05-22

METHODS AND COMPOSITIONS FOR REDUCING THE RISK OF ADVERSE CARDIOVASCULAR EVENTS ASSOCIATED WITH THE ADMINISTRATION OF ARTIFICIAL BLOOD

#232
20080113901
2008-05-15

Use of an agent that restores tissue perfusion and oxygenation

#233
20080108555
2008-05-08

Method and apparatus for preparing an acellular red blood cell substitute

#234
20080107724
2008-05-08

Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules

#235
20080107637
2008-05-08

Use of an agent that restores tissue perfusion and oxygenation

#236
20080096805
2008-04-24

Nitric oxide-blocked cross-linked tetrameric hemoglobin

#237
20080090222
2008-04-17

Virus-Inactivated Hemoglobin And Method Of Producing The Same

#238
20080075742
2008-03-27

Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components

#239
20070270333
2007-11-22

Methods of treating acute blood loss

#240
20070265195
2007-11-15

Multifunctional blood substitute

#241
20070238641
2007-10-11

Pharmaceutical combined preparation containing a therapeutic protein

#242
20070196810
2007-08-23

Polymerized Hemoglobin Media and its Use in Isolation and Transplantation of Islet Cells

#243
20070184027
2007-08-09

Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases

#244
20070173435
2007-07-26

Stabilized hemoglobin solutions

#245
20070167352
2007-07-19

Method for making a high oxygen affinity modified hemoglobin for oxygen transport

#246
20070134197
2007-06-14

Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination

#247
20070129287
2007-06-07

Hemoglobin conjugates

#248
20070100015
2007-05-03

Gels for encapsulation of biological materials

#249
20070065521
2007-03-22

Composition and method for treating iron deficiency anemia

#250
20070049517
2007-03-01

Use of hyperpolymeric hemoglobin for the treatment of pulmonary edema

#251
20070031474
2007-02-08

Implantable preparations

#252
20070014764
2007-01-18

Reduction in myocardial infarction size

#253
20060287222
2006-12-21

Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing

#254
20060276374
2006-12-07

Use of an agent that restores tissue perfusion and oxygenation

#255
20060264357
2006-11-23

Capillary membrane stabilization and reduction of tissue injury through use of biodegradable macromolecules with antioxidants and/or other chemicals

#256
20060249456
2006-11-09

Method of removing carbon monoxide from an oxygen carrier and apparatus for removing carbon monoxide

#257
20060247423
2006-11-02

Hemoglobin conjugate and the preparation method and its use

#258
20060234915
2006-10-19

Compositions and methods for delivering carbon monoxide (CO) and nitric oxide (NO) to tissue using heme proteins as carriers

#259
20060211601
2006-09-21

Nitrosated and nitrosylated heme proteins

#260
20060210644
2006-09-21

Materials, methods, and devices for treatment of arthropathies and spondylopathies

#261
20060182807
2006-08-17

Copolymer and hemoprotein based novel compounds and uses thereof

#262
20060172924
2006-08-03

Methods to enhance hemodynamic stability using oxygen carrying compositions

#263
20060160724
2006-07-20

Preserving a hemoglobin blood substitute with a transparent overwrap

#264
20060134186
2006-06-22

Oxygenating agents for enhancing host responses to microbial infections

#265
20060088583
2006-04-27

Artificial oxygen carrier containing preventive agents of metHb formation

#266
20060084137
2006-04-20

Use of defibrinated blood for manufacture of hemoglobin-based oxygen carrier

#267
20060057725
2006-03-16

Therapeutic retroviral vectors for gene therapy

#268
20060039898
2006-02-23

Method of skin care and/or treatment using rice (Oryza sativa) hemoglobin or other hexacoordinated, non-symbiotic plant hemoglobins

#269
20060014671
2006-01-19

Stabilized hemoglobin solutions

#270
20050266050
2005-12-01

Antimicrobial composition and method for use

#271
20050239686
2005-10-27

Methods and compositions for optimization of oxygen transport by cell-free systems

#272
20050239069
2005-10-27

Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders

#273
20050197281
2005-09-08

Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins

#274
20050164915
2005-07-28

Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin

#275
20050129747
2005-06-16

Use of one or more natural or modified oxygen carriers, devoid of plasma and cellular membrane constiuents, for externally treating open, in particular chronic wounds

#276
20050123617
2005-06-09

Biodegradable polymeric nanocapsules and uses thereof

#277
20050123583
2005-06-09

Medical use of reuterin

#278
20050119161
2005-06-02

Methods and compositions for oxygen transport comprising an oxygen carrier and a crystalloid in hypertonic solution

#279
20050079162
2005-04-14

Method for improving oxygen transport by stored red blood cells

#280
20050065067
2005-03-24

Method and apparatus for preparing an acellular red blood cell substitute

#281
20050043218
2005-02-24

Inhibitor of stem cell proliferation and uses thereof

#282
20050026816
2005-02-03

Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin

#283
20050025757
2005-02-03

Oxygen carrier system, artificial oxygen carrier, and reducing agent

#284
20050020485
2005-01-27

Methods and compositions for oxygen transport comprising modified hemoglobin in plasma

#285
20050009736
2005-01-13

Methods and compositions for optimization of oxygen transport by cell-free systems